← Devices & Neurotechnology
Details checkedClinical trial listing onlyCheckedregistry
Sudden-deafness nerve-block plus mecobalamin study
Also known as: Mecobalamin Tablets, Stellate ganglion block sudden deafness study
Investigator-led study
Sponsor / Institution
Investigator-led study
Program Type
Procedure/Rehab
Modality
Nerve Block/Medication Combination Study
Stage
Not applicable
Status
Unknown
Target Gene
—
Route / Mode
Nerve block plus oral mecobalamin
Confidence
83%
Status Confidence
Status needs checking
Evidence Strength
Needs more support
Last Reviewed
2026-06-10
Geography
China
Population
adult, sudden-hearing-loss
Trial IDs
1
Mechanism
Randomized study of stellate ganglion block with or without facial and glossopharyngeal nerve blocks, with mecobalamin tablets in all groups, for sudden deafness.
Indications
Notes
Registry-verified investigator-led procedure/medication combination study. The sponsor is an individual investigator and should not be displayed as a company.
Evidence & Sources
1 structured sourcesclinicaltrials
Supports: canonicalName, company, allCompanies, isIndustrySponsored, programType, modality, mechanism, indications...
IDs: NCT05623384
Key Events
Clinical Trials (1)
Data Checks
investigator-led-studyregistry-only-evidencecombination-intervention-studycurrent-status-unknown-in-registrynot-confirmed-current-product
Related Programs
Intratympanic injection anesthesia-method comparison study
Sponsor / Institution: Institution-led study · Procedural Anesthesia/Pain-Control Study · Not applicable
Tetracaine versus phenol intratympanic anesthesia study
Sponsor / Institution: Institution-led study · Procedural Anesthesia/Pain-Control Study · Early Phase 1
Prednisone plus stimulation sudden-deafness study
Sponsor / Institution: Investigator-led study · Combination Drug/Procedure Study · Not applicable